BDSI reaches settlement with generic drug giant Teva
February 07, 2018 at 08:17 AM EST
Raleigh-based BioDelivery Sciences International has settled the last of its outstanding patent litigation filed against generic manufacturing giant Teva Pharmaceuticals.
